The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
NCT ID: NCT02126189
Last Updated: 2015-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
600 participants
OBSERVATIONAL
2013-11-30
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All patients attending the Head and Neck Clinic at the Princess Alexandra Hospital is invited to complete a risk factor questionnaire and give consent for their clinical data and tissue samples to be available for future research activities. The risk factor questionnaire is based on existing validated instruments developed by the QIMR Berghofer Medical Research Institute Cancer Control Group, and will collect standardised information relating to demographics and causal factors (tobacco and alcohol intake), risk modifiers (dentition, asprin and non-steroidal anti-inflammatory drugs (NSAIDS), height, weight, physical activity, diet quality etc) and behaviours (oral sex etc)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma
NCT02156180
Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02705833
Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
NCT04666428
Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT06905145
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The questionnaires also ask participants some detailed questions about sexual behaviour and history if they are comfortable to give this information.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Head and neck cancer
All patients presenting to the Head and Neck Cancer Clinic at the Princess Alexandra Hospital, Brisbane, Australia are invited to participate.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
QIMR Berghofer Medical Research Institute
OTHER
Princess Alexandra Hospital, Brisbane, Australia
OTHER
Translational Research Institute, Brisbane, Australia
UNKNOWN
The University of Queensland
OTHER
Queensland Centre of Excellence for Head and Neck Cancer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annika Antonsson, Dr
Role: PRINCIPAL_INVESTIGATOR
QIMR Berghofer Medical Research Institute
Ben Panizza, Assoc Prof
Role: PRINCIPAL_INVESTIGATOR
Princess Alexandra Hospital
Sandro Porceddu, Assoc Prof
Role: PRINCIPAL_INVESTIGATOR
Princess Alexandra Hospital
David Whiteman, Prof
Role: PRINCIPAL_INVESTIGATOR
QIMR Berghofer Medical Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Princess Alexandra Hospital
Brisbane, Queensland, Australia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HREC13QPAH36
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.